Skip to main content
. 2021 Jun 4;41(12):3016–3021. doi: 10.1016/j.clnu.2021.05.024

Table 1.

Patient characteristics.

Patient characteristics Before protocol implementation (n = 48) Across protocol implementation (n = 47) After protocol implementation (n = 24)
Age (years), mean (±SD) 61.2 (±12.1) 65.2 (±10.2) 65.1 (±13.5)
Sex, n (%)
 Men 32 (66.7) 38 (80.9) 21 (87.5)
 Women 16 (33.3) 9 (19.1) 3 (12.5)
APACHE II score, mean (±SD) 21.7 (±9.5) 20.7 (±8.6) 21.5 (±7.6)
Comorbiditiesa, n (%)
 None 11 (22.9) 8 (17.0) 4 (16.7)
 Hypertension 23 (47.9) 27 (57.4) 9 (37.5)
 Diabetes 11 (22.9) 18 (38.2) 4 (16.6)
 Hypercholesterolemia 15 (31.2) 12 (25.5) 7 (29.1)
 Heart disease 13 (27.1) 10 (21.3) 6 (25.0)
 Smoking 3 (6.2) 9 (19.1) 7 (29.1)
 COPD 4 (8.3) 3 (6.4) 2 (8.3)
 Stroke 2 (4.2) 4 (8.5) 1 (4.2)
 Oncology 2 (4.2) 4 (8.5) 4 (8.3)
 Chronic renal failure 4 (8.3) 3 (6.4) 3 (12.5)
Admission weight (kg), mean (±SD) 84.9 (±13.4) 84.4 (±15.4) 88.1 (±26.5)
BMI n (%)
 <18.5 kg/m2 0 (0) 0 (0) 1 (4.2)
 18.5–24.9 kg/m2 3 (6.2) 8 (17.0) 6 (25.0)
 25.0–29.9 kg/m2 24 (50.0) 20 (42.5) 9 (37.5)
 ≥30.0 kg/m2 21 (43.8) 19 (40.5) 8 (33.3)
Ventilation, n (%)
Invasive mechanical ventilation 48 (100.0) 47 (100.0) 24 (100.0)
Non-invasive mechanical ventilation 16 (33.3) 23 (48.9) 11 (45.8)
High-flow nasal oxygenation 7 (14.6) 16 (34.0) 7 (29.2)
Acute renal failure with RRT, n (%) 6 (12.5) 6 (12.7) 3 (12.5)
Vasopressor therapy, n (%) 42 (87.5) 44 (93.6) 24 (100.0)
ICU length of stay (days), mean (±SD) 11.7 (±4.4) 22.2 (±9.1) 18.7 (±7.9)
Hospital length of stay (days), mean (±SD) 22.3 (+10.3) 38.1 (±15.1) 36.3 (±16.8)
 Discharge alive from ICU, n (%) 39 (81.2) 38 (80.9) 20 (83.3)

(APACHE II = Acute Physiology And Chronic Health Evaluation II; COPD=Chronic Obstructive Pulmonary Disease; BMI=Body Mass Index; ICU = Intensive Care Unit; RRT = Renal Replacement Therapy).

a

Patients could present with more than one comorbid condition, thus the percentages can add to more than 100%, or similar.